Comparison of utilization and cost of healthcare services and pharmacotherapy following implantation of vagus nerve stimulation <i>vs.</i> responsive neurostimulation or deep brain stimulation for the treatment of drug-resistant epilepsy: analyses of a large United States healthcare claims database

Tom Vincent, Qian Li, Lu Zhang, Michael E. Stokes, Vanessa Danielson, Joanna Murphy, Francesca Barion, Sandi Lam, Reginald Lassagne, Ariel Berger

Journal of Medical Economics · 2022 · 12 citations · 24 references

DOIFull text

Open access

Abstract

After matching, VNS was associated with significantly lower all-cause and epilepsy-related costs for the two-year period following implantation. All-cause and epilepsy-related costs remained statistically significantly lower for VNS even after costs of implantation were excluded.

References

24